Academic History

Kevin Kalinsky is the Director of the Glenn Family Breast Center at Winship Cancer Institute, GA, and an Associate Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, Atlanta, GA. He completed his MD at the Medical University of South Carolina, Columbia, SC, in 2002, followed by an Internal Medicine internship (2003) and residency (2005) at Tufts Medical Center, Boston, MA. Dr Kalinsky pursued Hematology/Oncology fellowships at Tufts Medical Center (2008) and Memorial Sloan Kettering Cancer Center, New York, NY (2009).

Speaking on advancements in breast cancer therapies

Dr Kalinsky focuses on developing innovative therapeutic approaches for patients with early-stage and metastatic breast cancer. His research involves designing clinical trials, including pivotal studies like the HERA trial, which evaluated trastuzumab in HER2-positive early breast cancer and established its role in improving disease-free survival. Dr Kalinsky assesses novel agents based on tumor genomics and is actively funded by prestigious organizations, including the National Institutes of Health and the Breast Cancer Research Foundation. His contributions also explore the risk of late recurrence in estrogen-driven breast tumors through advanced blood markers and artificial intelligence.